Rosemarie Tremblay-LeMay, Nasrin Rastgoo, Maryam Pourabdollah, & Hong Chang. (2018). EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies. BMC.
Chicago Style (17th ed.) CitationRosemarie Tremblay-LeMay, Nasrin Rastgoo, Maryam Pourabdollah, and Hong Chang. EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies. BMC, 2018.
MLA (9th ed.) CitationRosemarie Tremblay-LeMay, et al. EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies. BMC, 2018.
Warning: These citations may not always be 100% accurate.